Earnings History Data for Mesoblast Limited (MESO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Mesoblast Limited

Mesoblast Limited is a global leader in developing innovative cell-based medicines. The Company has leveraged its proprietary technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a broad portfolio of late-stage product candidates. Mesoblast's allogeneic, 'off-the-shelf' cell product candidates target advanced stages of diseases with high, unmet medical needs including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
27-02-2023 AH MESO Mesoblast Limited 487.00 -0.17 -0.15 0.00 3.32 0.12 
(3.75%)
3.30 0.10 
(3.12%)
2.14 - 4.94 77,260 100,000 693
22-11-2022 PM MESO Mesoblast Limited 455.21 -0.12 -0.09 -0.17 Mesoblast GAAP EPS of -$0.0243 beats by $0.14, revenue of $1.5M misses by $1.82M
[11/23/2022 2:11 AM]
3.35 0.10 
(3.08%)
3.41 0.16 
(4.92%)
2.14 - 6.92 82,156 80,000 1,500
30-08-2022 PM MESO Mesoblast Limited 437.11 -0.17 -0.08 -0.17 Mesoblast GAAP EPS of -$0.14, revenue of $10.21M
[8/31/2022 5:16 AM]
3.00 0.27 
(9.89%)
2.89 0.16 
(5.86%)
2.14 - 7.28 75,242 50,000 2,452
23-11-2021 AH After the close
(Nov 23)
MESO Mesoblast Limited 810.00 -0.17 -0.15 0.00 Mesoblast EPS beats by $0.10, beats on revenue
[11/23/2021 11:00 PM]
6.36 -0.11 
(-1.70%)
6.23 -0.24 
(-3.67%)
5.52 - 17.41 92,010 190,000 673
02-06-2021 PM After the close
(Jun 2)
MESO Mesoblast Limited 999.39 -0.22 -0.10 -0.14 Mesoblast reports FQ3 results
[6/3/2021 1:34 AM]
7.09 -0.45 
(-5.97%)
7.32 -0.22 
(-2.92%)
6.67 - 21.28 205,854 130,000 1,998
19-11-2020 AH MESO Mesoblast Limited 1,380 -0.21 0.08 0.00 Mesoblast EPS beats by $0.22, misses on revenue
[11/19/2020 5:43 PM]
13.84 2.05 
(17.39%)
13.70 1.91 
(16.20%)
3.12 - 21.28 1,931,053 336,440 63,874